This company has been marked as potentially delisted and may not be actively trading. Eiger BioPharmaceuticals (EIGR) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock EIGR Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period New Route On Eiger's North Face Will Have to WaitApril 16, 2025 | msn.comRemembering John Harlin, Eiger LegendMarch 23, 2025 | msn.comEiger BioPharmaceuticals Inc (OTC:EIGRQ) Stock Quotes, Forecast and News SummaryOctober 6, 2024 | benzinga.comEiger Biopharmaceuticals Inc (EIGRQ)September 29, 2024 | investing.comMassive Rockfall on the North Face of the EigerSeptember 8, 2024 | yahoo.comEiger BioPharmaceuticals, Inc. (EIGRQ)August 13, 2024 | finance.yahoo.com72C.SG,0P00015QPW,0 (72C.SG)August 3, 2024 | ca.finance.yahoo.comFirm Retention Summary: Eiger BioPharmaceuticalsMay 1, 2024 | wsj.comRequiem for Eiger BiopharmaceuticalsApril 8, 2024 | wsj.comPeninsula biotech files for Chapter 11 bankruptcy protectionApril 2, 2024 | bizjournals.comEiger BioPharmaceuticals Files for BankruptcyApril 1, 2024 | wsj.comHealthcare stocks fade as obesity-drug optimism fadesApril 1, 2024 | marketwatch.comMetabolic Diseases-Focused Eiger BioPharmaceuticals Files For Bankruptcy, Stock NosedivesApril 1, 2024 | msn.comEiger Biopharmaceuticals Files for Chapter 11 BankruptcyApril 1, 2024 | finance.yahoo.comEiger BioPharmaceuticals (Nasdaq:EIGR) HeadlineTrading was temporarily halted for "EIGR" at 12:04 PM with a stated reason of "LULD pause."...April 1, 2024 | marketbeat.comEiger BioPharmaceuticals (Nasdaq:EIGR) HeadlineTrading was temporarily halted for "EIGR" at 11:04 AM with a stated reason of "LULD pause." Trading set to resume at 12:04 PM. April 1, 2024 | marketbeat.comEiger BioPharmaceuticals (Nasdaq:EIGR) HeadlineTrading was temporarily halted for "EIGR" at 12:04 PM with a stated reason of "LULD pause."...April 1, 2024 | marketbeat.comEiger reportedly files for Chapter 11, stock plunges 52%April 1, 2024 | msn.comEiger BioPharmaceuticals (Nasdaq:EIGR) HeadlineTrading was temporarily halted for "EIGR" at 11:04 AM with a stated reason of "LULD pause." Trading set to resume at 11:04 AM. April 1, 2024 | marketbeat.comEiger BioPharmaceuticals (Nasdaq:EIGR) HeadlineTrading was temporarily halted for "EIGR" at 11:04 AM with a stated reason of "LULD pause."...April 1, 2024 | marketbeat.comEiger BioPharmaceuticals (Nasdaq:EIGR) HeadlineTrading was temporarily halted for "EIGR" at 11:04 AM with a stated reason of "LULD pause."...April 1, 2024 | marketbeat.comEiger BioPharmaceuticals Files for Voluntary Chapter 11 ProtectionApril 1, 2024 | globenewswire.comEiger BioPharmaceuticals (Nasdaq:EIGR) HeadlineTrading was temporarily halted for "EIGR" at 10:04 AM with a stated reason of "LULD pause."...April 1, 2024 | marketbeat.comEiger BioPharmaceuticals (Nasdaq:EIGR) HeadlineTrading was temporarily halted for "EIGR" at 10:04 AM with a stated reason of "LULD pause." Trading set to resume at 10:04 AM. April 1, 2024 | marketbeat.comEiger BioPharmaceuticals (Nasdaq:EIGR) HeadlineTrading was temporarily halted for "EIGR" at 10:04 AM with a stated reason of "LULD pause." Trading set to resume at 10:04 AM. April 1, 2024 | marketbeat.comEiger BioPharmaceuticals (Nasdaq:EIGR) HeadlineTrading was temporarily halted for "EIGR" at 10:04 AM with a stated reason of "LULD pause."...April 1, 2024 | marketbeat.comEIGR Eiger BioPharmaceuticals, Inc.March 20, 2024 | seekingalpha.comEiger BioPharmaceuticals (Nasdaq:EIGR) HeadlineTrading was temporarily halted for "EIGR" at 09:03 AM with a stated reason of "LULD pause."...March 4, 2024 | marketbeat.comNew Natomas industrial property owner Eiger Capital could be buying more local assetsFebruary 8, 2024 | bizjournals.comPanattoni sells part of Natomas Advanced Logistics Center to Eiger CapitalFebruary 4, 2024 | bizjournals.comEiger and Partner, AnGes, Receive Approval for Zokinvy® (lonafarnib) for Hutchinson- Gilford Progeria Syndrome and Processing-Deficient Progeroid Laminopathies in JapanJanuary 18, 2024 | finance.yahoo.comEiger BioPharmaceuticals (Nasdaq:EIGR) HeadlineTrading was temporarily halted for "EIGR" at 07:01 PM with a stated reason of "News pending."...January 8, 2024 | marketbeat.comEiger BioPharmaceuticals announces 1-for-30 reverse stock splitJanuary 4, 2024 | msn.comEiger BioPharmaceuticals, Inc. Announces 1-for-30 Reverse Stock SplitJanuary 4, 2024 | finance.yahoo.com‘Bob Eiger’ Trends on X After Elon Musk Blasts the Disney CEO With Multi-Tweet TypoDecember 7, 2023 | yahoo.comEiger BioPharmaceuticals Insiders US$2.1m Short Of Breakeven On Stock PurchaseDecember 4, 2023 | finance.yahoo.comEiger BioPharmaceuticals, Inc.: Eiger BioPharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business UpdateNovember 11, 2023 | finanznachrichten.deAnalysts Are Bullish on These Healthcare Stocks: Ocular Therapeutix (OCUL), Eiger Biopharmaceuticals (EIGR)September 15, 2023 | markets.businessinsider.comEiger BioPharmaceuticals Shares Hit New Lows After Scrapped Hepatitis D StudySeptember 13, 2023 | marketwatch.comEiger To Discontinue Peginterferon Lambda Trial In CHD Patients; Stock Down In PremarketSeptember 13, 2023 | markets.businessinsider.comWhy Is Hepatitis Player Eiger BioPharma Stock Trading Lower Today?September 13, 2023 | msn.comWhy Is Eiger BioPharmaceuticals (EIGR) Stock Down 31% Today?September 13, 2023 | investorplace.comEiger to discontinue late-stage hepatitis drug study over safety concernsSeptember 13, 2023 | reuters.comEiger to discontinue hepatitis drug study over safety concernsSeptember 12, 2023 | news.yahoo.comEiger BioPharmaceuticals to Discontinue Chronic Hepatitis Delta Study, Ends Licensing TalksSeptember 12, 2023 | marketwatch.comEiger to stop late stage trial in hepatitis D patients, stock slumps ~36% after hoursSeptember 12, 2023 | seekingalpha.comUPDATE 1-Eiger to discontinue hepatitis drug study over safety concernsSeptember 12, 2023 | finance.yahoo.comEiger to discontinue hepatitis drug studySeptember 12, 2023 | reuters.comEiger BioPharmaceuticals (Nasdaq:EIGR) HeadlineTrading was temporarily halted for "EIGR" at 04:09 PM with a stated reason of "News pending."...September 12, 2023 | marketbeat.comCiti Sticks to Their Buy Rating for Eiger Biopharmaceuticals (EIGR)August 30, 2023 | markets.businessinsider.com Get Eiger BioPharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for EIGR and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. EIGR Media Mentions By Week EIGR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EIGR News Sentiment▼0.000.92▲Average Medical News Sentiment EIGR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EIGR Articles This Week▼00▲EIGR Articles Average Week Get the Latest News and Ratings for EIGR and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Eiger BioPharmaceuticals and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Adial Pharmaceuticals News Today 60 Degrees Pharmaceuticals News Today Alpha Tau Medical News Today BriaCell Therapeutics News Today enGene News Today Fortress Biotech News Today GeoVax Labs News Today Jasper Therapeutics News Today NewAmsterdam Pharma News Today Nutriband News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EIGR) was last updated on 9/17/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eiger BioPharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Eiger BioPharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free EIGR Stock Alerts